Latest Breaking News On - News ratings for crinetics pharmaceuticals daily - Page 3 : vimarsana.com

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51.60

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51.60
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Richard-scott-struthers
Stephenf-betz
Robertw-baird
Crinetics-pharmaceuticals-inc
Jennison-associates
Securities-exchange-commission
Crinetics-pharmaceuticals
Victory-capital-management-inc
Nasdaq
Charles-schwab-investment-management-inc
News-ratings-for-crinetics-pharmaceuticals-daily
Crinetics-pharmaceuticals-stock

HC Wainwright Reiterates "Buy" Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)

HC Wainwright Reiterates "Buy" Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Piper-sandler
Richard-scott-struthers
Dana-pizzuti
Crinetics-pharmaceuticals
Citigroup
Highmark-wealth-management
Crinetics-pharmaceuticals-trading-down
News-ratings-for-crinetics-pharmaceuticals-daily
Securities-exchange-commission
China-universal-asset-management-co
Cantor-fitzgerald

Insider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CEO Sells $5,307,931.20 in Stock

Insider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CEO Sells $5,307,931.20 in Stock
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
Robertw-baird
Richard-scott-struthers
Vanguard-group-inc
Quarter-for-crinetics-pharmaceuticals
News-ratings-for-crinetics-pharmaceuticals-daily
Cantor-fitzgerald
Jennison-associates
Crinetics-pharmaceuticals
Morgan-stanley

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Matthewk-fust
Piper-sandler
Dana-pizzuti
Crinetics-pharmaceuticals
Vanguard-group-inc
Jennison-associates
News-ratings-for-crinetics-pharmaceuticals-daily
Morgan-stanley
Analyst-recommendations-for-crinetics-pharmaceuticals
Crinetics-pharmaceuticals-stock-performance
Cantor-fitzgerald
Securities-exchange-commission

E Fund Management Co. Ltd. Acquires 2,914 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

E Fund Management Co. Ltd. Acquires 2,914 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Dana-pizzuti
Richard-scott-struthers
Piper-sandler
Crinetics-pharmaceuticals
Morgan-stanley
Jennison-associates
Quarter-for-crinetics-pharmaceuticals
Vanguard-group-inc
Crinetics-pharmaceuticals-trading-down
Securities-exchange-commission
Insider-activity-at-crinetics-pharmaceuticals
Crinetics-pharmaceuticals-profile